Latest Articles

Publication Date
Advanced Management of Severe Adenomyosis in IVF: A Personalized Approach With Extended GnRH Agonist and Letrozole Therapy.

The objective of this study is to evaluate the effectiveness of prolonged GnRH agonist (GnRH-a) suppression combined with letrozole and intensive luteal phase support in a patient with severe adenomyosis …

Published: March 9, 2026, midnight
[Endometriose i klinisk praksis].

Endometriosis is a chronic, estrogen-dependent inflammatory disorder affecting ~10% of reproductive-age women. It is underdiagnosed, with delays of 5-12 years. Symptoms include dysmenorrhea, chronic pelvic pain, dyspareunia, dyschezia, dysuria, fatigue, …

Published: March 9, 2026, midnight
Pernille Bjerre Trent: Publishes New Article on Avoiding Radiotherapy in Endometrial Carcinoma - Oncodaily

Pernille Bjerre Trent: Publishes New Article on Avoiding Radiotherapy in Endometrial Carcinoma Oncodaily

Published: March 7, 2026, 6:34 p.m.
How physiotherapy is helping endometriosis patients in Ireland feel less alone - her.ie

How physiotherapy is helping endometriosis patients in Ireland feel less alone her.ie

Published: March 6, 2026, 1:42 p.m.
Metformin sensitizes endometriosis to medroxyprogesterone acetate treatment through MIG-6 mediated signaling.

This study evaluates the synergistic therapeutic effect of metformin (MET) combined with medroxyprogesterone acetate (MPA) on endometriosis (EM) and investigates the involvement of the steroid receptor coactivator-1 (SRC-1) and mitogen-inducible …

Published: March 6, 2026, midnight
Short-Term Vaginal Estrogen Therapy Does Not Increase Risks of Endometrial Cancer Recurrence - The ASCO Post

Short-Term Vaginal Estrogen Therapy Does Not Increase Risks of Endometrial Cancer Recurrence The ASCO Post

Published: March 5, 2026, 4:20 p.m.
Vaginal estrogen therapy not associated with increased risk of endometrial cancer recurrence - Contemporary OB/GYN

Vaginal estrogen therapy not associated with increased risk of endometrial cancer recurrence Contemporary OB/GYN

Published: March 5, 2026, 12:23 a.m.
Lactoferrin as a Non-Hormonal Therapeutic Candidate for Endometriosis: Mechanisms and Future Directions.

The pathogenesis and progression of endometriosis may involve a complex combination of multiple factors, including chronic inflammation and oxidative stress. Hormonal therapy, the current standard for pharmacotherapy in endometriosis, causes …

Published: March 5, 2026, midnight
Navigating menopausal health in Oman (Marie Oman WP2a).

Published: March 5, 2026, midnight
Vaginal estrogen therapy not linked to cancer recurrence in survivors of endometrial cancer - Medical Xpress

Vaginal estrogen therapy not linked to cancer recurrence in survivors of endometrial cancer Medical Xpress

Published: March 4, 2026, 11:40 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!